Serum thyroid hormone indexes in patients with primary hyperparathyroidism

Area of Science:

• Endocrinology
• Nephrology
• Thyroidology

Background:

• Serum reverse triiodothyronine (rT3) levels differ between renal diseases and nonthyroidal illnesses.
• The role of secondary hyperparathyroidism in renal disease on rT3 levels is not fully understood.

Purpose of the Study:

• To investigate the influence of parathyroid hormone (PTH) excess on serum thyroid hormone levels, specifically rT3.
• To differentiate the impact of primary hyperparathyroidism (PHP) from other causes of hypercalcemia on thyroid hormone profiles.

Main Methods:

• Studied serum thyroid hormone levels (total T3, rT3, T4, T3 uptake ratio, free T4 index, thyrotropin) in 27 patients with PHP and normal renal function.
• Compared these levels with those in patients experiencing hypercalcemia due to malignant neoplasms and healthy controls.
• Correlated thyroid hormone levels with PTH levels in PHP patients.

Main Results:

• Patients with PHP showed reduced total T3 and rT3 levels, correlating with PTH levels.
• Serum rT3 levels were significantly elevated in hypercalcemic cancer patients with low PTH.
• Thyroid hormone levels, except for total T3 and rT3, remained unaltered in PHP.

Conclusions:

• PTH excess may be responsible for the failure of serum rT3 levels to increase in primary hyperparathyroidism and secondary hyperparathyroidism associated with renal disease.
• This suggests a distinct mechanism influencing rT3 regulation in different hypercalcemic states.